BUY Mold-Tek Packaging Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred 1 year)3 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Small-cap stock jumps 8% after Q2 Results 2026 | Will the rally continue? Target, stop-loss
NewsLivemint·3 Nov · 4d ago
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·3 Nov · 4d ago
Mold-TekPackagingsharessurge17% as Q2FY27profitjumps35% YoY to Rs21crore
NewsEt-Markets·2 Nov · 5d ago
Mold-Tek Packaging Limited reported strong Q2 FY2027 financial results with a 36.06% increase in net profit and 30.73% growth in revenue compared to the same quarter last year.
NSE · Press Release·2 Nov · 5d ago
Mold-Tek Packaging reported strong Q2 FY2027 results with a 36.06% increase in net profit and 30.73% growth in revenue, driven by robust performance in Pharma and Food & FMCG packaging segments.
BSE · Company Update·2 Nov · 5d ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Mold-Tek Packaging
- BUY — Axis Securities3 Nov 2026 · ~1 year · target ₹450 · Active
- BUY — Prabhudas Lilladher2 Nov 2026 · ~1 year · target ₹345 · Target hit
- BUY — Axis Securities29 Aug 2026 · ~1 year · target ₹380 · Active
- BUY — IDBI Capital28 Jul 2026 · ~1 year · target ₹403 · Active
- BUY — Prabhudas Lilladher27 Jul 2026 · ~1 year · target ₹730 · Target hit
More from IDBI Capital
- BUY Alkem Laboratories6 Nov 2026 · ~2 weeks · target ₹5,460 · Active
- BUY Onesource Specialty Pharma6 Nov 2026 · ~2 weeks · target ₹1,735 · Active
- BUY Sun Pharmaceutical Industries6 Nov 2026 · ~2 weeks · target ₹1,925 · Active
- BUY Vijaya Diagnostic Centre6 Nov 2026 · ~2 weeks · target ₹1,575 · Active
- BUY Rolex Rings6 Nov 2026 · ~1 year · target ₹241 · Active

